Category: Technology (Page 1 of 3)

Dr. Noze Best NoseBot

Exciting News from Our Portfolio Company, Dr. Noze Best!

We are thrilled to share a significant achievement from our portfolio company, Dr. Noze Best. It’s official – their pediatrician-approved nasal aspirator for children is available at Target!

At Dr. Noze Best, their dedication to children’s well-being and development shines through. With this innovative nasal aspirator, they are making it easier than ever for families to provide gentle and effective care for their little ones.

Learn more about Dr. Noze Best on their website.

Celebrating Musheer Ahmed: Biolocity Portfolio Company CEO Named Georgia Tech’s 40 under 40

We are thrilled to congratulate Musheer Ahmed, the CEO and Founder of Codoxo, a Biolocity portfolio company, for being recognized as one of The Georgia Tech Alumni Association’s 40 under 40 honorees!

Musheer’s exceptional leadership, innovation, and dedication have undoubtedly significantly impacted the biotech industry. As a part of the Biolocity family, we couldn’t be prouder of his achievements and the transformative work Codoxo is doing in healthcare.

This prestigious recognition is a testament to Musheer’s vision and contributions as an inspiring entrepreneur and a Georgia Tech alum. His forward-thinking approach has driven Codoxo’s success, positioning the company as a key player in the biotech landscape.

To view all the inspiring awardees recognized by The Georgia Tech Alumni Association’s 40 under 40, click here:

Congratulations once again, Musheer! Your dedication and achievements are an inspiration to us all.

NephroDI Therapeutics Strikes Deal for Revolutionary Kidney Disease Treatment


NephroDI Therapeutics, a Biolocity portfolio company, has made waves in the medical field with its recent agreement to develop a first-in-class treatment for a rare genetic disease affecting the kidneys. This development brings new hope to patients and their families who have been waiting for a targeted therapy to address congenital Nephrogenic Diabetes Insipidus (NDI). This collaboration is a testament to the power of scientific innovation and industry partnerships in driving advancements in healthcare and improving patient outcomes.

Learn more about this exciting news here.

Page 1 of 3

Powered by WordPress & Theme by Anders Norén